New York City Department of Parks and Recreation employees caught the 4-foot alligator in a lake in Prospect Park after ...

Weight-loss injections work by mimicking a natural hormone, GLP-1, which regulates hunger, and those who use them find their ...

TV commercials were my childhood TikTok before any of us were using terms like “short-form video.” But like most creative ...

How Greg and Anna Brockman became MAGA’s newest megadonors• The Takeway: When a Davos trip presents a chance to test AI’s ...

Axsome Therapeutics, Inc. has three marketed CNS drugs and pipeline potential in Alzheimer's and narcolepsy. Read why AXSM stock is a buy.

Heineken, Chubb, and India stocks are in our panelists’ sights this year. How to assemble your own sports portfolio.

The Trade Desk will have to contend with increased competition and shifting industry patterns over the next half-decade.

OpenAI has begun testing advertising in ChatGPT. Ad experts said OpenAI will need to prove a chatbot can actually sell.

Consumers continued to ramp up their spending as the holiday shopping season kicked into high gear in November, but inflation continued to bite, new data showed Thursday.

OpenEvidence closed a $250 million funding round, doubling its valuation to $12 billion as its ad-supported AI tool gains traction with US physicians.

An alternative is to simply pay more than the minimum amount due every month on all of your debts. The more you pay, the ...

Daniel Nadler, the 42-year-old CEO and cofounder of OpenEvidence, is now worth $7.6 billion as his AI search tool surges in popularity among U.S. doctors.